INS and diabetes mellitus: Patients with LLA had lower rates of statins, antiplatelet therapy, ACE inhibitors and Angiotensin Receptor Blockers, metformin and insulin prescriptions at baseline compared to those without diabetes-related LLA (p < 0.001).